FDA Inspection 1274884 — Shandong Lukang Shelile Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Lukang Shelile Pharmaceutical Co., Ltd. on May 30, 2025 in Jining. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 30, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Jining (China)